Spirit Airlines CEO: Frontier takeover bid is ‘a really positive deal in a difficult market’July 3, 2022
Share Facebook Twitter LinkedIn Pinterest Email Beam Therapeutics Inc. (BEAM) delivered earnings and revenue surprises of 8.18% and 89.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
